LASA
Invest Now
Start SIP in
LASA
Performance
- Low
- ₹18
- High
- ₹19
- 52 Week Low
- ₹17
- 52 Week High
- ₹33
- Open Price₹18
- Previous Close₹18
- Volume87,582
Investment Returns
- Over 1 Month + 5.78%
- Over 3 Month -15.93%
- Over 6 Month -28.27%
- Over 1 Year -21.07%
Smart Investing Starts Here Start SIP with Lasa Supergenerics for Steady Growth!
Lasa Supergenerics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -5.9
- PEG Ratio
- -0.2
- Market Cap Cr
- 93
- P/B Ratio
- 1
- Average True Range
- 1.03
- EPS
- 0
- Dividend Yield
- 0
- MACD Signal
- -0.47
- RSI
- 54.46
- MFI
- 77.71
Lasa Supergenerics Financials
Lasa Supergenerics Technicals
EMA & SMA
Current Price
₹18.47
+
0.22
(1.21%)

-
- Bearish Moving Average 7
-
- Bullish Moving Average 9
- 20 Day
- ₹17.84
- 50 Day
- ₹19.13
- 100 Day
- ₹21.19
- 200 Day
- ₹23.23
Resistance and Support
18.42
- R3 19.65
- R2 19.22
- R1 18.85
- S1 18.05
- S2 17.62
- S3 17.25
Lasa Supergenerics Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-05-26 | Audited Results | |
2025-02-13 | Quarterly Results | |
2025-01-28 | Others | Inter-alia, to consider 1. The issue of warrants. 2. Proposal of fund raising by way of equity shares through rights issue. 3. Other business matters. per share(2.5%)Final Dividend |
2024-11-14 | Quarterly Results | |
2024-08-14 | Quarterly Results |
Lasa Supergenerics F&O
About Lasa Supergenerics
- NSE Symbol
- LASA
- BSE Symbol
- 540702
- Chairman & Managing Director
- Dr. Omkar Pravin Herlekar
- ISIN
- INE670X01014
Similar Stocks to Lasa Supergenerics
Lasa Supergenerics FAQs
Lasa Supergenerics share price is ₹18 As on 19 May, 2025 | 01:56
The Market Cap of Lasa Supergenerics is ₹92.5 Cr As on 19 May, 2025 | 01:56
The P/E ratio of Lasa Supergenerics is -5.9 As on 19 May, 2025 | 01:56
The PB ratio of Lasa Supergenerics is 1 As on 19 May, 2025 | 01:56
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.